About: Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study
Creator	Xiong, Tao Hu, Qin-Ming Huang, Zhi-Ping Tang, Yuan-Yan Xu, Xuan-Xuan Yang, Ai-Ying Yin, Hai-Sen Yu, Bao-Ping Zhao, Xin-Ying
source	Medline; PMC
abstract	BACKGROUND: Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. METHODS: We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. RESULTS: Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. CONCLUSIONS: Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.
has issue date	2020-04-29(xsd:dateTime)
bibo:doi	10.1186/s12879-020-05010-w
bibo:pmid	32345226
has license	cc-by
sha1sum (hex)	08b8071e86c9e39314fad083588214ce40b33ee7
schema:url	https://doi.org/10.1186/s12879-020-05010-w
resource representing a document's title	Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study
has PubMed Central identifier	PMC7188494
has PubMed identifier	32345226
schema:publication	BMC Infect Dis
resource representing a document's body	covid:08b8071e86c9e39314fad083588214ce40b33ee7#body_text
is schema:about of	named entity 'worldwide' named entity 'CAUSE' named entity 'AREAS' named entity 'infected' named entity 'December' named entity 'clinical characteristics' named entity 'China' named entity 'Wuhan' named entity 'Hubei Province' named entity '2019 coronavirus disease' named entity 'glucocorticoids' named entity 'antibacterial agents' named entity 'aspartate aminotransferase' named entity 'seminal vesicle' named entity 'infection' named entity 'nucleic acid amplification' named entity 'glucocorticoid' named entity 'MERS' named entity 'angiotensin' named entity 'PCR amplification' named entity 'Jingzhou' named entity 'Acute respiratory distress syndrome' named entity 'SARS-CoV-2' named entity 'gastrointestinal problems' named entity 'CK-MB' named entity 'glucocorticoid' named entity 'prothrombin time' named entity 'multiple organ failure' named entity 'computed tomography' named entity 'COVID' named entity 'mortality rate' named entity 'laboratory tests' named entity 'chronic diseases' named entity 'Wuhan' named entity 'influenza' named entity 'viral pneumonia' named entity 'corticosteroids' named entity 'pneumonia' named entity 'microarray database' named entity '2019 coronavirus disease' named entity 'Middle East respiratory syndrome' named entity 'lopinavir/ritonavir' named entity 'kidneys' named entity 'renal injury' named entity 'biomarkers' named entity 'liver' named entity 'Oseltamivir' named entity 'infection' named entity 'qPCR' named entity 'creatine kinase' named entity 'myalgia' named entity 'antibacterial' named entity 'denaturation' named entity 'fever' named entity 'SARS-CoV-2' named entity 'organ' named entity 'Liver' named entity 'mortality rate' named entity 'liver' named entity 'corticosteroid therapy' named entity 'inflammation' named entity 'China' named entity 'epidemiological' named entity 'epidemiological' named entity 'renal function' named entity 'clinical diagnosis' named entity 'La Jolla' named entity 'oseltamivir' named entity 'Jingzhou' named entity 'umifenovir' named entity 'mortality rate' named entity 'lung cancer' named entity 'CK-MB'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software